Modern world well on its way to a semiconductor-powered future

Dr. Venkat Mattela, Founder and CEO of Ceremorphic, a leading semiconductor startup, shared his thoughts on the year that was for the industry, and what the new year is going to bring us.

As our lives get more intertwined with technology, the modern world is well on its way to a semiconductor-powered future. India’s semiconductor ambitions have undoubtedly reached global repute with government initiatives, investment in Research and Development, and collaborations aimed at streamlining the industry. In fact, as the global semiconductor industry is projected to become a trillion-dollar industry by 2030; India is well-positioned to become a global hub for the segment.

Not only this, but at the heart of today’s modern technology, semiconductors are driving the value-creation trends across several industries, especially life sciences. The use of semiconductor technology, namely the use of high-performance processors has led to breakthroughs in advanced precision medicine and genomic solutions – enabling a revolution in prevention, diagnosis, and treatment.

As we now look back, 2023 was the year for personalized healthcare, with improvements being made in patient safety, satisfaction, and experience. There was a greater push for collaboration to enhance R&D in the field and the recent explosion of generative AI tools prompted many discussions in accelerating biomedical research.

As we stand at the cusp of a new era, we can see how semiconductors, have become indispensable tools in this space, contributing to advancements in research, diagnostics, medical devices, and healthcare technologies. Taking this a notch higher, the coming year 2024 will witness the collaborative power of AI, with analog and quantum circuits to accelerate drug discovery and development, resulting in personalized treatments with better outcomes and lower costs.

Advanced AI-driven analytics will create relevant data to increase efficiency and reduce development cycles across analog design migration, digital design, verification, and testing. As Generative AI continues to mature, it will be able to predict regulatory queries and incorporate correct answers from the get-go, improving regulatory submissions and saving precious time when trying to get a drug to market.

There will be an increase in intermarket collaboration especially between the pharmaceutical and semiconductor industries to scale up manufacturing for green, clean, and emerging technologies. As we head into the new year, we will see an unprecedented efficiency in the drug discovery pipeline in this decade along with significant progress in lessening the side effects.

All this will be made possible with new and high-performance semiconductor technology that will enable modelling of cells and tissues more accurately in silicon to enable molecular simulation much faster.

Ongoing research and development will continue to push the boundaries of what is possible in semiconductor technology, especially for life sciences. By embracing this potential of semiconductors, the industry is poised to revolutionize healthcare delivery, ushering in an era where precision, efficiency, and patient-centric approaches define the standard of care.